S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
S&P 500   3,323.63 (+0.06%)
DOW   29,164.85 (-0.07%)
QQQ   224.38 (+0.22%)
AAPL   318.96 (+0.40%)
FB   220.34 (-0.44%)
MSFT   166.17 (+0.28%)
GOOGL   1,486.65 (+0.17%)
AMZN   1,887.00 (-0.02%)
NVDA   252.78 (+1.09%)
BABA   219.53 (-1.28%)
MU   59.27 (+0.15%)
GE   11.80 (+3.78%)
TSLA   572.58 (+0.53%)
AMD   51.63 (+0.39%)
T   38.68 (-0.95%)
F   9.11 (-0.55%)
NFLX   343.09 (+5.24%)
BAC   34.23 (-0.38%)
DIS   142.07 (-1.35%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:GWR - Genesee & Wyoming Stock Price, Forecast & News

$111.88
0.00 (0.00 %)
(As of 01/23/2020 03:02 PM ET)
Today's Range
$111.88
Now: $111.88
$111.88
50-Day Range
$110.15
MA: $111.57
$111.92
52-Week Range
$70.15
Now: $111.88
$111.97
VolumeN/A
Average Volume861,689 shs
Market Capitalization$6.38 billion
P/E Ratio29.06
Dividend YieldN/A
Beta1.33
Genesee & Wyoming Inc owns and leases freight railroads. It operates through three segments: North American Operations, Australian Operations, and U.K./European Operations. The company transports various commodities, including agricultural products, autos and auto parts, chemicals and plastics, coal and coke, food and kindred products, lumber and forest products, metallic ores, metals, minerals and stone, petroleum products, pulp and paper, waste, and other commodities. Read More…

Industry, Sector and Symbol

Industry Railroads, line-haul operating
Sub-IndustryRailroads
SectorTransportation
CUSIP37155910
Phone203-202-8900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.35 billion
Cash Flow$8.73 per share
Book Value$63.83 per share

Profitability

Net Income$244.42 million

Miscellaneous

Employees8,000
Market Cap$6.38 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive GWR News and Ratings via Email

Sign-up to receive the latest news and ratings for GWR and its competitors with MarketBeat's FREE daily newsletter.


Genesee & Wyoming (NYSE:GWR) Frequently Asked Questions

What is Genesee & Wyoming's stock symbol?

Genesee & Wyoming trades on the New York Stock Exchange (NYSE) under the ticker symbol "GWR."

How were Genesee & Wyoming's earnings last quarter?

Genesee & Wyoming Inc (NYSE:GWR) announced its quarterly earnings data on Wednesday, November, 6th. The transportation company reported $1.22 EPS for the quarter, missing the Zacks' consensus estimate of $1.30 by $0.08. The transportation company earned $583.69 million during the quarter. Genesee & Wyoming had a return on equity of 6.34% and a net margin of 9.28%. View Genesee & Wyoming's Earnings History.

When is Genesee & Wyoming's next earnings date?

Genesee & Wyoming is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Genesee & Wyoming.

What price target have analysts set for GWR?

7 equities research analysts have issued twelve-month price objectives for Genesee & Wyoming's stock. Their forecasts range from $69.00 to $112.00. On average, they anticipate Genesee & Wyoming's stock price to reach $100.94 in the next twelve months. This suggests that the stock has a possible downside of 9.8%. View Analyst Price Targets for Genesee & Wyoming.

What is the consensus analysts' recommendation for Genesee & Wyoming?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesee & Wyoming in the last year. There are currently 2 sell ratings, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Genesee & Wyoming.

Has Genesee & Wyoming been receiving favorable news coverage?

Media headlines about GWR stock have been trending somewhat positive on Thursday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genesee & Wyoming earned a daily sentiment score of 1.8 on InfoTrie's scale. They also assigned news stories about the transportation company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Genesee & Wyoming.

Are investors shorting Genesee & Wyoming?

Genesee & Wyoming saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 3,890,000 shares, an increase of 7.8% from the November 28th total of 3,610,000 shares. Based on an average trading volume of 607,000 shares, the days-to-cover ratio is currently 6.4 days. Currently, 7.0% of the shares of the company are sold short. View Genesee & Wyoming's Current Options Chain.

Who are some of Genesee & Wyoming's key competitors?

What other stocks do shareholders of Genesee & Wyoming own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesee & Wyoming investors own include Union Pacific (UNP), Exxon Mobil (XOM), Norfolk Southern (NSC), Micron Technology (MU), NVIDIA (NVDA), Verizon Communications (VZ), Netflix (NFLX), YRC Worldwide (YRCW), Bristol-Myers Squibb (BMY) and Metlife (MET).

Who are Genesee & Wyoming's key executives?

Genesee & Wyoming's management team includes the folowing people:
  • Mr. John C. Hellmann, Chairman, CEO & Pres (Age 49)
  • Mr. Timothy J. Gallagher, Chief Financial Officer (Age 56)
  • Ms. Allison M. Fergus, Gen. Counsel & Sec. (Age 45)
  • Mr. Matthew O. Walsh, Exec. VP of Global Corp. Devel. (Age 44)
  • Mr. Christopher F. Liucci, Chief Accounting Officer and Global Controller (Age 50)

Who are Genesee & Wyoming's major shareholders?

Genesee & Wyoming's stock is owned by many different of institutional and retail investors. Top institutional investors include Vertex One Asset Management Inc. (0.10%). Company insiders that own Genesee & Wyoming stock include Allison M Fergus, Christopher F Liucci, David A Brown, John C Hellmann, Matthew O Walsh and Timothy J Gallagher. View Institutional Ownership Trends for Genesee & Wyoming.

Which major investors are selling Genesee & Wyoming stock?

GWR stock was sold by a variety of institutional investors in the last quarter, including Vertex One Asset Management Inc.. View Insider Buying and Selling for Genesee & Wyoming.

How do I buy shares of Genesee & Wyoming?

Shares of GWR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Genesee & Wyoming's stock price today?

One share of GWR stock can currently be purchased for approximately $111.88.

How big of a company is Genesee & Wyoming?

Genesee & Wyoming has a market capitalization of $6.38 billion and generates $2.35 billion in revenue each year. The transportation company earns $244.42 million in net income (profit) each year or $3.85 on an earnings per share basis. Genesee & Wyoming employs 8,000 workers across the globe.View Additional Information About Genesee & Wyoming.

What is Genesee & Wyoming's official website?

The official website for Genesee & Wyoming is http://www.gwrr.com/.

How can I contact Genesee & Wyoming?

Genesee & Wyoming's mailing address is 20 WEST AVENUE, DARIEN CT, 06820. The transportation company can be reached via phone at 203-202-8900.


MarketBeat Community Rating for Genesee & Wyoming (NYSE GWR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  444 (Vote Outperform)
Underperform Votes:  365 (Vote Underperform)
Total Votes:  809
MarketBeat's community ratings are surveys of what our community members think about Genesee & Wyoming and other stocks. Vote "Outperform" if you believe GWR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GWR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel